ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/11/19 | 1,440 | 1,440 | 1,389 | 1,394 | -46 | -3.2% | 437,000 |
| 2020/11/18 | 1,428 | 1,447 | 1,410 | 1,440 | +2 | +0.1% | 300,900 |
| 2020/11/17 | 1,470 | 1,481 | 1,423 | 1,438 | -42 | -2.8% | 568,900 |
| 2020/11/16 | 1,453 | 1,496 | 1,443 | 1,480 | +41 | +2.8% | 769,000 |
| 2020/11/13 | 1,411 | 1,466 | 1,409 | 1,439 | +14 | +1% | 650,200 |
| 2020/11/12 | 1,423 | 1,436 | 1,404 | 1,425 | -48 | -3.3% | 867,400 |
| 2020/11/11 | 1,439 | 1,488 | 1,437 | 1,473 | +45 | +3.2% | 994,700 |
| 2020/11/10 | 1,430 | 1,470 | 1,412 | 1,428 | +28 | +2% | 1,230,000 |
| 2020/11/09 | 1,424 | 1,424 | 1,380 | 1,400 | -7 | -0.5% | 505,300 |
| 2020/11/06 | 1,389 | 1,433 | 1,380 | 1,407 | +7 | +0.5% | 839,800 |
| 2020/11/05 | 1,348 | 1,401 | 1,341 | 1,400 | +53 | +3.9% | 1,243,800 |
| 2020/11/04 | 1,302 | 1,352 | 1,293 | 1,347 | +90 | +7.2% | 1,099,000 |
| 2020/11/02 | 1,260 | 1,266 | 1,238 | 1,257 | +10 | +0.8% | 541,500 |
| 2020/10/30 | 1,300 | 1,308 | 1,238 | 1,247 | -69 | -5.2% | 846,600 |
| 2020/10/29 | 1,276 | 1,317 | 1,270 | 1,316 | +30 | +2.3% | 478,600 |
| 2020/10/28 | 1,298 | 1,300 | 1,279 | 1,286 | -17 | -1.3% | 384,300 |
| 2020/10/27 | 1,253 | 1,306 | 1,250 | 1,303 | +24 | +1.9% | 551,300 |
| 2020/10/26 | 1,286 | 1,303 | 1,273 | 1,279 | -6 | -0.5% | 350,300 |
| 2020/10/23 | 1,271 | 1,294 | 1,253 | 1,285 | +22 | +1.7% | 442,100 |
| 2020/10/22 | 1,316 | 1,317 | 1,262 | 1,263 | -57 | -4.3% | 794,100 |
| 2020/10/21 | 1,302 | 1,332 | 1,287 | 1,320 | +19 | +1.5% | 424,700 |
| 2020/10/20 | 1,327 | 1,328 | 1,293 | 1,301 | -25 | -1.9% | 728,500 |
| 2020/10/19 | 1,313 | 1,344 | 1,304 | 1,326 | +1 | +0.1% | 385,000 |
| 2020/10/16 | 1,351 | 1,358 | 1,313 | 1,325 | -25 | -1.9% | 930,500 |
| 2020/10/15 | 1,365 | 1,383 | 1,350 | 1,350 | -16 | -1.2% | 606,600 |
| 2020/10/14 | 1,381 | 1,388 | 1,365 | 1,366 | -15 | -1.1% | 471,000 |
| 2020/10/13 | 1,408 | 1,417 | 1,375 | 1,381 | -21 | -1.5% | 847,600 |
| 2020/10/12 | 1,392 | 1,422 | 1,379 | 1,402 | +12 | +0.9% | 450,800 |
| 2020/10/09 | 1,387 | 1,391 | 1,368 | 1,390 | +8 | +0.6% | 373,000 |
| 2020/10/08 | 1,405 | 1,405 | 1,377 | 1,382 | -15 | -1.1% | 558,000 |
| 2020/10/07 | 1,394 | 1,414 | 1,390 | 1,397 | -21 | -1.5% | 361,200 |
| 2020/10/06 | 1,419 | 1,428 | 1,389 | 1,418 | -1 | -0.1% | 543,900 |
| 2020/10/05 | 1,364 | 1,430 | 1,364 | 1,419 | +67 | +5% | 1,196,100 |
| 2020/10/02 | 1,375 | 1,385 | 1,349 | 1,352 | -21 | -1.5% | 814,600 |
| 2020/09/30 | 1,386 | 1,423 | 1,373 | 1,373 | -8 | -0.6% | 887,900 |
| 2020/09/29 | 1,377 | 1,407 | 1,374 | 1,381 | +8 | +0.6% | 670,400 |
| 2020/09/28 | 1,376 | 1,439 | 1,352 | 1,373 | +7 | +0.5% | 3,481,300 |
| 2020/09/25 | 1,354 | 1,367 | 1,339 | 1,366 | +20 | +1.5% | 385,900 |
| 2020/09/24 | 1,366 | 1,366 | 1,337 | 1,346 | -30 | -2.2% | 714,900 |
| 2020/09/23 | 1,370 | 1,380 | 1,341 | 1,376 | -3 | -0.2% | 541,900 |
| 2020/09/18 | 1,370 | 1,385 | 1,365 | 1,379 | +15 | +1.1% | 466,600 |
| 2020/09/17 | 1,410 | 1,410 | 1,359 | 1,364 | -58 | -4.1% | 1,193,700 |
| 2020/09/16 | 1,399 | 1,423 | 1,393 | 1,422 | +20 | +1.4% | 576,800 |
| 2020/09/15 | 1,405 | 1,408 | 1,383 | 1,402 | +8 | +0.6% | 401,400 |
| 2020/09/14 | 1,388 | 1,421 | 1,382 | 1,394 | +5 | +0.4% | 620,600 |
| 2020/09/11 | 1,394 | 1,394 | 1,350 | 1,389 | +10 | +0.7% | 570,200 |
| 2020/09/10 | 1,412 | 1,416 | 1,367 | 1,379 | -15 | -1.1% | 748,400 |
| 2020/09/09 | 1,366 | 1,411 | 1,362 | 1,394 | ±0 | ±0% | 807,900 |
| 2020/09/08 | 1,347 | 1,394 | 1,335 | 1,394 | +53 | +4% | 817,200 |
| 2020/09/07 | 1,343 | 1,363 | 1,325 | 1,341 | +5 | +0.4% | 1,088,800 |
951～
1000
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
